monkeypox
monkeypox
Explore linked clinical trials. Standard reference: MONDO:000259434 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC) | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-08-31 | NCT07093489 | |
| New York City Observational Study of Mpox Immunity | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Enrolling by invitation | Not stated | 2026-08-27 | NCT05654883 | |
| Smart Analysis and Decision-Making for Emerging Infectious Diseases | Alphavirus infectious disease, COVID-19, Communicable Diseases, Emerging, Coronaviridae Infections, DNA Virus Infections, Disease Attributes, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, avian influenza, bird disease, chikungunya, dengue disease, infectious disease, influenza, lung disorder, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rodent disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease, viral pneumonia | Enrolling by invitation | Not applicable | 2026-08-19 | NCT07678619 | |
| Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 4 | 2026-08-12 | NCT05745987 | |
| A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa | DNA Virus Infections, Infections, Orthopoxvirus Infection, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Recruiting | Phase 2 | 2026-08-11 | NCT07379580 | |
| Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-07-07 | NCT05562323 | |
| Validation of SDS-EDTA-Treated Chromatography Paper Strips for Mpox Sampling and Transport in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-06-11 | NCT07634081 | |
| Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 4 | 2026-06-11 | NCT07499739 | |
| Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-05-26 | NCT05597735 | |
| An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-05-19 | NCT06839989 | |
| Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Not applicable | 2026-05-18 | NCT07592429 | |
| Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-04-29 | NCT06844487 | |
| Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Not stated | 2026-04-16 | NCT07534267 | |
| Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-04-08 | NCT07199569 | |
| Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-03-19 | NCT05879965 | |
| Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-01-30 | NCT06844500 | |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. | DNA Virus Infections, Infections, cowpox, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Recruiting | Phase 1 | 2026-01-29 | NCT07377175 | |
| Prospective Follow-up After MVA-BN Booster Vaccination | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Not stated | 2026-01-20 | NCT07342829 | |
| Neutralizing Power of Serum Antibodies - 2 | COVID-19, Coronaviridae Infections, DNA Virus Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rodent disease, viral infectious disease, viral pneumonia | Recruiting | Not applicable | 2025-12-19 | NCT07085611 | |
| Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Phase 2 | 2025-11-28 | NCT07253675 | |
| Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 2 | 2025-11-24 | NCT06549530 | |
| A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Phase 1 | 2025-10-03 | NCT06771479 | |
| Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 3 | 2025-09-04 | NCT06223919 | |
| Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2) | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Enrolling by invitation | Not stated | 2025-07-16 | NCT07067723 | |
| Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1) | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Enrolling by invitation | Not stated | 2025-07-09 | NCT07055867 |